Floatz logo

Raltitrexed

Transarterial Chemoembolization

Peking University Cancer Hospital & InstituteSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Transarterial Chemoembolization cohort.

Asset / SponsorPhaseRating
HYDROMORPHONE HYDROCHLORIDE CII
First Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Theprubicin
Xinrui Zhu，MD
Phase 3BB
Amitriptyline
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
SUFENTANYL
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Ethiodized Oil
Xinrui Zhu，MD
Phase 3BB

View all 13 →

Same molecule, other indications

Raltitrexed is also rated in:

Hepatic Arterial Infusion ChemotherapyDormant
BBB
Indicative ·
74 / 100
View asset →
Colon Cancer Liver MetastasisDormant
BB
Indicative ·
71 / 100
View asset →
Hepatocellular CarcinomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →